Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1999-3-11
|
pubmed:abstractText |
Previous studies have demonstrated that topoisomerase I is cleaved late during apoptosis, but have not identified the proteases responsible or examined the functional consequences of this cleavage. Here, we have shown that treatment of purified topoisomerase I with caspase-3 resulted in cleavage at DDVD146 downward arrowY and EEED170 downward arrowG, whereas treatment with caspase-6 resulted in cleavage at PEDD123 downward arrowG and EEED170 downward arrowG. After treatment of Jurkat T lymphocytic leukemia cells with anti-Fas antibody or A549 lung cancer cells with topotecan, etoposide, or paclitaxel, the topoisomerase I fragment comigrated with the product that resulted from caspase-3 cleavage at DDVD146 downward arrowY. In contrast, two discrete topoisomerase I fragments that appeared to result from cleavage at DDVD146 downward arrowY and EEED170 downward arrowG were observed after treatment of MDA-MB-468 breast cancer cells with paclitaxel. Topoisomerase I cleavage did not occur in apoptotic MCF-7 cells, which lack caspase-3. Cell fractionation and band depletion studies with the topoisomerase I poison topotecan revealed that the topoisomerase I fragment remains in proximity to the chromatin and retains the ability to bind to and cleave DNA. These observations indicate that topoisomerase I is a substrate of caspase-3 and possibly caspase-6, but is cleaved at sequences that differ from those ordinarily preferred by these enzymes, thereby providing a potential explanation why topoisomerase I cleavage lags behind that of classical caspase substrates such as poly(ADP-ribose) polymerase and lamin B1.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CASP6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 6,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9258
|
pubmed:author |
pubmed-author:AlnemriE SES,
pubmed-author:BasiG SGS,
pubmed-author:ChampouxJ JJJ,
pubmed-author:DurrieuFF,
pubmed-author:EarnshawW CWC,
pubmed-author:KaufmannS HSH,
pubmed-author:KottkeTT,
pubmed-author:MesnerP WPWJr,
pubmed-author:PoirierG GGG,
pubmed-author:SamejimaKK,
pubmed-author:StewartLL,
pubmed-author:SvingenP APA
|
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4335-40
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9933635-Animals,
pubmed-meshheading:9933635-Apoptosis,
pubmed-meshheading:9933635-Caspase 3,
pubmed-meshheading:9933635-Caspase 6,
pubmed-meshheading:9933635-Caspases,
pubmed-meshheading:9933635-Catalytic Domain,
pubmed-meshheading:9933635-DNA Topoisomerases, Type I,
pubmed-meshheading:9933635-Humans,
pubmed-meshheading:9933635-Jurkat Cells,
pubmed-meshheading:9933635-Peptide Fragments,
pubmed-meshheading:9933635-Recombinant Proteins,
pubmed-meshheading:9933635-Spodoptera
|
pubmed:year |
1999
|
pubmed:articleTitle |
Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis.
|
pubmed:affiliation |
Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR, Scotland, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|